Michael Sotiriou, MD
Dermatology · Salt Lake City, UTNPI 1780097105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,431 and has fallen 99.8% since, to $3 in 2025.
Across 164 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$613
- Sun Pharmaceutical Industries Inc.$383
- Prugen, Inc. Pharmaceuticals$265
- Sanofi$247
- Lilly USA, LLC$211
- Pfizer$186
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,997100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $613 |
| Sun Pharmaceutical Industries Inc. | 27 | $383 |
| Prugen, Inc. Pharmaceuticals | 5 | $265 |
| Sanofi | 11 | $247 |
| Lilly USA, LLC | 10 | $211 |
| Pfizer | 13 | $186 |
| Galderma Laboratories, L.p. | 11 | $159 |
| Almirall LLC | 6 | $132 |
| Novartis | 6 | $128 |
| LEO Pharma Inc. | 7 | $116 |
| VYNE Pharmaceuticals Inc. | 4 | $99 |
| UCB, Inc. | 4 | $98 |
| EPI Health, LLC | 8 | $81 |
| Johnson & Johnson | 3 | $72 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Mayne Pharma Commercial LLC | 1 | $36 |
| Amgen | 1 | $25 |
| Mission Pharmacal Company | 2 | $23 |
| DUSA Pharmaceuticals, Inc. | 1 | $15 |
| Encore Dermatology Inc. | 1 | $12 |
| Organon | 1 | $3 |
How this compares
$3,011 in reported general payments places this provider in the 65th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 37 | $1,538 |
| Ketoconazole | 46 | $606 |
| Triamcinolone Acetonide | 39 | $436 |
| Doxycycline Hyclate | 18 | $247 |
| Hydroxyzine Hcl | 15 | $206 |
| Hydrocortisone | 18 | $141 |
| Mupirocin | 11 | $104 |
| Cephalexin | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Salt Lake City
- Gerald KruegerSalt Lake City$156K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
- Stephanie ZoneSalt Lake City$22K
- Lauren MadiganSalt Lake City$21K
- Elena HadjicharalambousSalt Lake City$9K
- Grace BrummerSalt Lake City$4K
- Megan ProutySalt Lake City$3K
- Dev SahniSalt Lake City$3K
- Margaret CocksSalt Lake City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.